Gleditsia caspica

Gleditsia caspica · Accepted scientific name

Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆

Gleditsia caspica is a unique botanical species that has garnered significant scientific interest due to its complex biological properties. Research focusing on the plant's fruit has revealed remarkable medicinal potential, particularly regarding its therapeutic activities. Specifically, the fruit exhibits potent antigenotoxic and antitumor effects that warrant further investigation. These properties are especially notable for their ability to mitigate chromosomal aberrations within cellular structures. Consequently, this plant represents a promising subject for future pharmacological developments in cancer prevention and genetic protection.

Quick facts
Synonyms
Gleditsia Darwinni · Gleditsia Horrida Subsp. Caspica · 6 more
Common names
Not available
Family
Fabaceae
Distribution
Not available
Plant Parts
Fruit

Classification

Common Names

Gleditsia caspica is a unique species known by a diverse array of names across different languages and regions. In English-speaking areas, it is frequently referred to as either the Caspian locust or the Persian honeylocust. Its reach extends into Portuguese-speaking communities, where it is commonly called the espinheiro-do-cáspio. Slavic speakers identify the plant through terms such as glediczja kaspijska or gledíčia kaspická. These varied common names highlight the widespread recognition and cultural presence of this distinctive tree.

Sources: Catalogue of Life (COL)

Synonyms

Gleditsia caspica is a complex species characterized by several recognized taxonomic synonyms. Scientific literature identifies this plant under various names, including Caesalpiniodes caspicum and Gleditsia darwinni. Furthermore, the species encompasses specific varieties such as Gleditsia caspica var. platycarpa and Gleditsia caspica var. subvirescens. It is also categorized under the subspecies designation Gleditsia horrida subsp. caspica in certain classifications. Understanding these varying relationships is essential for accurate botanical identification and study.

Sources: The World Checklist of Vascular Plants (WCVP)

Taxonomy

Gleditsia caspica is a distinctive member of the kingdom Plantae. Within this vast biological realm, the species is classified under the class Equisetopsida. It belongs to the order Fabales, which helps define its evolutionary lineage. Further narrowing its botanical identity, the plant is part of the Fabaceae family. Ultimately, this specimen is defined by its placement within the genus Gleditsia.

Rank Classification
Kingdom Plantae
Phylum Streptophyta
Class Equisetopsida
Subclass Magnoliidae
Order Fabales
Family Fabaceae
Genus Gleditsia

Sources: The World Checklist of Vascular Plants (WCVP)

Distribution

Geographic Regions

Gleditsia caspica is a notable species with a broad geographical footprint spanning multiple regions across Asia and Europe. In the temperate zones of Asia, it can be found stretching from the Caucasus and Transcaucasus through to Central Asia. Its presence is specifically documented within the borders of Turkmenistan and Uzbekistan, highlighting its importance in those landscapes. The species also extends into Western Asia, where it thrives within the territory of Iran. Furthermore, its distribution reaches into Eastern Europe, specifically including parts of Ukraine.

Sources: The World Checklist of Vascular Plants (WCVP)

Identification

Morphology

Gleditsia caspica is characterized by its distinctive growth form as a tree.

Sources: Global Inventory of Floras and Traits (GIFT)

Biological Activities

Gleditsia caspica exhibits significant biological potential through its unique triterpenoid saponin profile. Research into its fruit extracts has revealed that these compounds possess notable antigenotoxic properties. Specifically, the total saponin fraction has been shown to significantly inhibit chromosomal aberrations induced by cyclophosphamide in both bone marrow and germ cells. Furthermore, the plant demonstrates promising antitumor activity by reducing the viability of the human MCF-7 tumor cell line in a dose-dependent manner. These findings highlight the therapeutic relevance of the gleditsiosides found within this species.

Compounds

Conditions

Gleditsia caspica possesses significant biological properties, including the ability to treat chromosomal aberrations in bone marrow and germ cells. The plant's saponin fraction demonstrates a protective effect that treats cyclophosphamide-induced genotoxicity in mice. Specifically, it significantly inhibits the number of chromosomal abnormalities caused by the administration of cyclophosphamide. Furthermore, the extract effectively treats the viability of the human tumor cell line MCF-7 by reducing it in a dose-dependent manner. These findings highlight the plant's potential for both antigenotoxic and anti-tumor applications.

Preparations

Parts used

Gleditsia caspica produces distinct fruits that serve as a rich source of bioactive triterpenoid saponins. Researchers have successfully isolated specific compounds, such as gleditsiosides B, C, and Q, from methanolic extracts of these fruits. Studies indicate that the saponin fraction derived from the fruit possesses significant antigenotoxic properties by inhibiting chromosomal aberrations in mice. Furthermore, these fruit-derived extracts demonstrate a dose-dependent ability to reduce the viability of human MCF-7 tumor cells. This highlights the potential medicinal value found within the various components of the Gleditsia caspica fruit.